ID

26874

Descripción

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00949598

Link

https://clinicaltrials.gov/show/NCT00949598

Palabras clave

Versiones (1)
  1. 27/10/17 27/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00949598

Inglés

Eligibility Breast Cancer NCT00949598

1 formularios  
Criteria
Descripción

Criteria

histologically confirmed invasive breast adenocarcinoma
Descripción

Breast adenocarcinoma Invasive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0205281
clinically t2 tumor and/or > 1 cm by echography
Descripción

TNM Breast tumor staging Ultrasonography | Tumor size Ultrasonography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0474926
UMLS CUI [1,2]
C0041618
UMLS CUI [2,1]
C0475440
UMLS CUI [2,2]
C0041618
estrogen receptor (er)-positive and > 10% of the tumor cells positive
Descripción

Estrogen receptor positive | Neoplastic Cell Positive Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279754
UMLS CUI [2,1]
C0597032
UMLS CUI [2,2]
C1514241
UMLS CUI [2,3]
C0439165
no er-negative disease
Descripción

Exclusion | Disease Estrogen receptor negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0279756
no prior breast cancer
Descripción

Exclusion | Breast Carcinoma Previous

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0205156
no metastatic or inflammatory breast adenocarcinoma
Descripción

Exclusion Criteria | Breast adenocarcinoma metastatic | Breast adenocarcinoma inflammatory

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C1697918
UMLS CUI [3,1]
C0858252
UMLS CUI [3,2]
C0333348
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
postmenopausal
Descripción

Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
no cardiac function that could contraindicate surgery or medical treatment (e.g., radiotherapy and/or chemotherapy)
Descripción

Exclusion Criteria | Cardiac function Contraindicated Operative Surgical Procedures | Cardiac function Contraindicated Therapeutic procedure | Therapeutic radiology procedure | Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0232164
UMLS CUI [2,2]
C1444657
UMLS CUI [2,3]
C0543467
UMLS CUI [3,1]
C0232164
UMLS CUI [3,2]
C1444657
UMLS CUI [3,3]
C0087111
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0392920
no prior malignancies within the past 5 years except for nonmelanoma skin cancer or carcinoma in situ of the cervix
Descripción

Exclusion | Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0006826
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
no mental incapacitation that would preclude consent
Descripción

Exclusion | Mental handicap Preventing Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C1306341
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0021430
no contraindication to tamoxifen citrate or letrozole
Descripción

Exclusion Criteria | Medical contraindication Tamoxifen Citrate | Medical contraindication letrozole

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0079589
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0246421
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
more than 8 days since prior hormone-replacement therapy or other treatment (i.e., phytoestrogen) for menopause
Descripción

Hormone replacement therapy | Therapeutic procedure Menopause | phytoestrogen therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0282402
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0025320
UMLS CUI [3]
C1541283
no concurrent therapy that would modify the expression of the genes regulated by estrogen
Descripción

Exclusion | Therapeutic procedure Changing Estrogen Gene Expression Regulation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0392747
UMLS CUI [2,3]
C0014939
UMLS CUI [2,4]
C0017263
no concurrent participation in another clinical study
Descripción

Study Subject Participation Status | Exclusion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C2828389
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00949598

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Breast adenocarcinoma Invasive
Item
histologically confirmed invasive breast adenocarcinoma
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
TNM Breast tumor staging Ultrasonography | Tumor size Ultrasonography
Item
clinically t2 tumor and/or > 1 cm by echography
boolean
C0474926 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
Estrogen receptor positive | Neoplastic Cell Positive Percentage
Item
estrogen receptor (er)-positive and > 10% of the tumor cells positive
boolean
C0279754 (UMLS CUI [1])
C0597032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Exclusion | Disease Estrogen receptor negative
Item
no er-negative disease
boolean
C2828389 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0279756 (UMLS CUI [2,2])
Exclusion | Breast Carcinoma Previous
Item
no prior breast cancer
boolean
C2828389 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Exclusion Criteria | Breast adenocarcinoma metastatic | Breast adenocarcinoma inflammatory
Item
no metastatic or inflammatory breast adenocarcinoma
boolean
C0680251 (UMLS CUI [1])
C1697918 (UMLS CUI [2])
C0858252 (UMLS CUI [3,1])
C0333348 (UMLS CUI [3,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Exclusion Criteria | Cardiac function Contraindicated Operative Surgical Procedures | Cardiac function Contraindicated Therapeutic procedure | Therapeutic radiology procedure | Chemotherapy
Item
no cardiac function that could contraindicate surgery or medical treatment (e.g., radiotherapy and/or chemotherapy)
boolean
C0680251 (UMLS CUI [1])
C0232164 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C0232164 (UMLS CUI [3,1])
C1444657 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4])
C0392920 (UMLS CUI [5])
Exclusion | Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix
Item
no prior malignancies within the past 5 years except for nonmelanoma skin cancer or carcinoma in situ of the cervix
boolean
C2828389 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Exclusion | Mental handicap Preventing Informed Consent
Item
no mental incapacitation that would preclude consent
boolean
C2828389 (UMLS CUI [1])
C1306341 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
Exclusion Criteria | Medical contraindication Tamoxifen Citrate | Medical contraindication letrozole
Item
no contraindication to tamoxifen citrate or letrozole
boolean
C0680251 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Hormone replacement therapy | Therapeutic procedure Menopause | phytoestrogen therapy
Item
more than 8 days since prior hormone-replacement therapy or other treatment (i.e., phytoestrogen) for menopause
boolean
C0282402 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0025320 (UMLS CUI [2,2])
C1541283 (UMLS CUI [3])
Exclusion | Therapeutic procedure Changing Estrogen Gene Expression Regulation
Item
no concurrent therapy that would modify the expression of the genes regulated by estrogen
boolean
C2828389 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0014939 (UMLS CUI [2,3])
C0017263 (UMLS CUI [2,4])
Study Subject Participation Status | Exclusion
Item
no concurrent participation in another clinical study
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial